Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Other Voices: As SEC`s comment period on short selling comes to an end, re-regulation may be necessary but over regulation is irresponsible

Wednesday, June 24, 2009

The following piece was authored by Dick Del Bello, a senior partner at Conifer Securities, LLC, a U.S.-based prime brokerage and provider of comprehensive business and operations solutions to hedge funds and investment managers.

Investors may end up holding the short end of the stick if the SEC isn't extremely careful in recommending proposed new regulations governing short sales. At stake will be the future of one of the free markets' best systems for policing and acting on corporate ineptitude.

While individual investors, be they retail, or institutional, may be hamstrung by the fortunes of an individual company in which they have invested long, the overall market is not. That is true because of the ability of investors to short a company's stock, in effect hedging their bet on a company's prospects. The decision to short may be based upon their opinion that the company's business plan, management, performance or products, warrant the stock being overvalued in comparison with its peers, or on an absolute basis.

Shorting in itself is one of the most important aspects in the business of market checks and balances that serves to keep regulatory filings honest, material disclosure complete and communications with the market above board. It is also one of the most misunderstood. The mere whiff of impropriety by the legions of cranially endowed short sellers can be a punishing tool for managements ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its